| [32] |
Beyfuss K, Hood DA. A systematic review of p53 regulation of oxidative stress in skeletal muscle[J]. Redox Rep, 2018, 23(1):100-117.
|
| [33] |
Meng Q, Xia Y. c-Jun, at the crossroad of the signaling network[J]. Protein Cell, 2011, 2(11):889-898.
|
| [34] |
Lan HC, Li HJ, Lin G, et al. Cyclic AMP stimulates SF-1-dependent CYP11A1 expression through homeodomain-interacting protein kinase 3-mediated Jun N-terminal kinase and c-Jun phosphorylation[J]. Mol Cell Biol, 2007, 27(6):2027-2036.
|
| [35] |
Shukla S, Pandey RK, Mishra S, et al. Epidermal growth factor receptor mutations in adenocarcinoma lung: Comparison of techniques for mutation detection[J]. Indian J Pathol Microbiol, 2022, 65(2):296-304.
|
| [36] |
Sur S, Agrawal DK. Transactivation of EGFR by G protein-coupled receptor in the pathophysiology of intimal hyperplasia[J]. Curr Vasc Pharmacol, 2014, 12(2):190-201.
|
| [37] |
Ho HJ, Shirakawa H, Giriwono PE, et al. A novel function of geranylgeraniol in regulating testosterone production[J]. Biosci Biotechnol Biochem, 2018, 82(6):956-962.
|
| [38] |
Grasing M, Kennedy K, Sarnak MJ, et al. Mild to moderate decrease in eGFR and cognitive decline in older adults[J]. Nephrol Dial Transplant, 2022, 37(8):1499-1506.
|
| [39] |
Nie H, Zheng Y, Li R, et al. Phosphorylation of FOXP3 controls regulatory T cell function and is inhibited by TNF-α in rheumatoid arthritis[J]. Nat Med, 2013, 19(3):322-328.
|
| [40] |
Kang S, Narazaki M, Metwally H, et al. Historical overview of the interleukin-6 family cytokine[J]. J Exp Med, 2020, 217(5):598-609.
|
| [1] |
Wang C, Nieschlag E, Swerdloff R, et al. Investigation, treatment and monitoring of late-onset hypogonadism in males[J]. Int J Androl, 2009, 32(1):1-10.
|
| [2] |
李宏军.男性迟发性性腺功能减退症的发病机制与流行病学[J].国际生殖健康/计划生育杂志，2011，30（1）：10-13.
|
| [3] |
廖波，邓显忠，李雨根，等.2018年上半年某城区中老年男性迟发性性腺功能减退症的流行病学调查[J].实用医药杂志，2019，36（6）：542-545.
|
| [4] |
Santos HO, Howell S, Teixeira FJ. Beyond tribulus (Tribulus terrestris L.): The effects of phytotherapics on testosterone, sperm and prostate parameters[J]. J Ethnopharmacol, 2019, 235:392-405.
|
| [5] |
郭三维，琚建军，李铮.男性性腺功能减退症的认识与对策[J].上海医学，2021，44（5）：302-306.
|
| [6] |
闵潇，焦拥政.中医药积极干预迟发性性腺功能减退症的临床意义与思路[J].中华中医药杂志，2018，33（8）：3483-3486.
|
| [7] |
李轩，何清湖，刘朝圣，等.天蚕壮阳散治疗男性更年期综合征临床观察[J].湖南中医药大学学报，2013，33（3）：73-75.
|
| [8] |
王孙亚，李望辉，宾东华，等.雄蚕益肾方联合小剂量睾酮补充治疗男性迟发性性腺功能减退症临床观察[J].湖南中医药大学学报，2018，38（8）：903-907.
|
| [9] |
司红梅，于旭东，商建伟，等.中医药治疗迟发性性腺功能减退症的系统评价与Meta分析[J].中国实验方剂学杂志，2021，27（3）：191-197.
|
| [10] |
国家药典委员会.中华人民共和国药典（2020年版一部）[M].北京：中国医药科技出版社，2020：3-402.
|
| [11] |
唐德才，吴庆光.中药学[M]. 3版.北京：人民卫生出版社，2016：37-382.
|
| [12] |
孙思邈.千金翼方[M].北京：中国医药科技出版社，2017：159.
|
| [13] |
沙图穆苏.瑞竹堂经验方[M].北京：中国医药科技出版社，2019：38.
|
| [14] |
沈泽铖，徐新宇，崔云，等.崔云基于"肝肾同源"理论辨治男性更年期综合征经验[J].浙江中医杂志，2021，56（9）：635-636.
|
| [15] |
代恒恒，冯隽龙，王继升，等.李曰庆教授运用开郁至神汤加减治疗男性更年期综合征的临床经验[J].现代中医临床，2020，27（4）：43-45.
|
| [16] |
张奇峰，张焱，丁毅.二仙汤治疗肾阴阳两虚型男性迟发性性腺功能减退症临床研究[J]. 南京中医药大学学报，2018，34（3）：269-272.
|
| [17] |
梁国庆，李建辉，施慧娟，等.迟发性性腺功能减退症病人血清雄激素及其相关代谢指标水平城乡差异分析[J].实用老年医学，2019，33（7）：701-705.
|
| [18] |
Perheentupa A, Huhtaniemi I. Aging of the human ovary and testis[J]. Mol Cell Endocrinol, 2009, 299(1):2-13.
|
| [19] |
Zhu X, Guo F, Tang H, et al. Islet transplantation attenuating testicular injury in type 1 diabetic rats is associated with suppression of oxidative stress and inflammation via Nrf-2/HO-1 and NF-κB pathways[J]. J Diabetes Res, 2019, 2019:8712492.
|
| [20] |
Grossmann M. Testosterone and glucose metabolism in men: Current concepts and controversies[J]. J Endocrinol, 2014, 220(3):R37-R55.
|
| [21] |
Tremellen K. Gut endotoxin leading to a decline IN Gonadal function (GELDING) - a novel theory for the development of late onset hypogonadism in obese men[J]. Basic Clin Androl, 2016, 26:7.
|
| [22] |
Fernandez CJ, Chacko EC, Pappachan JM. Male obesity-related secondary hypogonadism - pathophysiology, clinical implications and management[J]. Eur Endocrinol, 2019, 15(2):83-90.
|
| [23] |
George JT, Millar RP, Anderson RA. Hypothesis: Kisspeptin mediates male hypogonadism in obesity and type 2 diabetes[J]. Neuroendocrinology, 2010, 91(4):302-307.
|
| [24] |
Kilarkaje N, Al-Hussaini H. Type 1 diabetes upregulates metastasis-associated protein 1- phosphorylated histone 2AX signaling in the testis[J]. Eur J Pharmacol, 2019, 846:30-37.
|
| [25] |
Corona G, Vignozzi L, Sforza A, et al. Obesity and late-onset hypogonadism[J]. Mol Cell Endocrinol, 2015, 418 Pt 2:120-133.
|
| [26] |
Heron-Milhavet L, Khouya N, Fernandez A, et al. Akt1 and Akt2: Differentiating the aktion[J]. Histol Histopathol, 2011, 26(5):651-662.
|
| [27] |
Ren BC, Zhang YF, Liu SS, et al. Curcumin alleviates oxidative stress and inhibits apoptosis in diabetic cardiomyopathy via Sirt1-Foxo1 and PI3K-Akt signalling pathways[J]. J Cell Mol Med, 2020, 24(21):12355-12367.
|
| [28] |
Yin B, Bi YM, Fan GJ, et al. Molecular mechanism of the effect of huanglian jiedu decoction on type 2 diabetes mellitus based on network pharmacology and molecular docking[J]. J Diabetes Res, 2020, 2020:5273914.
|
| [29] |
Akinola OB, Gabriel MO. Neuroanatomical and molecular correlates of cognitive and behavioural outcomes in hypogonadal males[J]. Metab Brain Dis, 2018, 33(2):491-505.
|
| [30] |
Zheng X, Lin W, Jiang Y, et al. Electroacupuncture ameliorates beta-amyloid pathology and cognitive impairment in Alzheimer disease via a novel mechanism involving activation of TFEB (transcription factor EB)[J]. Autophagy, 2021, 17(11):3833-3847.
|
| [31] |
Olivier M, Hollstein M, Hainaut P. TP53 mutations in human cancers: Origins, consequences, and clinical use[J]. Cold Spring Harb Perspect Biol, 2010, 2(1):a001008.
|